Breaking News Instant updates and real-time market news.

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18

Dova Pharmaceuticals to hold a conference call

Conference call to discuss the FDA approval of the Company's New Drug Application (NDA) for DOPTELET (avatrombopag) for treatment of chronic Immune Thrombocytopenia (ITP) will be held on June 27 at 9 am. Webcast Link

  • 30

    Jun

DOVA Dova Pharmaceuticals
$10.56

0.27 (2.62%)

01/23/19
JPMS
01/23/19
DOWNGRADE
Target $20
JPMS
Underweight
JPMorgan double downgrades Dova on 'underwhelming' Doptelet launch
JPMorgan analyst Anupam Rama double downgraded Dova Pharmaceuticals to Underweight from Overweight and cut his price target for the shares to $20 from $34. While the analyst continues to view Doptelet "as a largely de-risked asset from a clinical standpoint," he believes focus in the near term will be on the launch in chronic liver disease, which he says "has underwhelmed thus far." Further, Rama thinks it may take several quarters for new management to put into motion a revised strategy. As such, he thinks Dova shares will underperform in the first half of 2019.
05/22/19
WEDB
05/22/19
INITIATION
Target $19
WEDB
Outperform
Dova Pharmaceuticals initiated with an Outperform at Wedbush
Wedbush analyst Laura Chico started Dova Pharmaceuticals with an Outperform rating and $19 price target.
05/23/19
05/23/19
INITIATION
Target $19

Outperform
Wedbush bullish on Dova Pharmaceuticals, initiates with an Outperform
As previously reported, Wedbush analyst Laura Chico started coverage of Dova Pharmaceuticals with an Outperform and a $19 price target. Although the company's Doptelet now enters its second year on the market, the analyst believes that in many ways it is still just getting started as it has gained a new CEO, Chief Commercial Officer and marketing message. Her proprietary physician survey suggests increasing utilization by hepatologists is still to come. Moreover, the recent partnership with Salix Pharmaceuticals can facilitate expanding the Doptelet footprint more broadly into the gastroenterology space, she contends.
06/25/19
HCWC
06/25/19
NO CHANGE
Target $18
HCWC
Buy
H.C. Wainwright says Dova EU approval as expected ahead of U.S. PDUFA for ITP
Dova Pharmaceuticals, as expected, announced that the European Commission approved the marketing of Doptelet for severe thrombocytopenia in adult patients with chronic liver disease, noted H.C. Wainwright analyst Joseph Pantginis. The analyst also noted that the U.S. PDUFA date for Doptelet in chronic ITP is June 30, though he believes that the FDA may act this coming Friday. Pantginis keeps a Buy rating on Dova shares with an $18 price target.

TODAY'S FREE FLY STORIES

MIRM

Mirum Pharmaceuticals

$0.00

(0.00%)

11:41
07/18/19
07/18
11:41
07/18/19
11:41
Syndicate
Mirum Pharmaceuticals indicated to open at $15.00, IPO priced at $15.00 »

Mirum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

11:35
07/18/19
07/18
11:35
07/18/19
11:35
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:35
07/18/19
07/18
11:35
07/18/19
11:35
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

KERN

Akerna

$13.25

-0.45 (-3.28%)

11:34
07/18/19
07/18
11:34
07/18/19
11:34
Hot Stocks
Akerna announces partnership agreement with Leafly »

Akerna Corp. and Leafly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$42.44

0.82 (1.97%)

11:30
07/18/19
07/18
11:30
07/18/19
11:30
Options
Vertical call spread buyer in Taiwan Semi opens 6 month position »

Vertical call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

BKNG

Booking Holdings

$1,871.84

4.82 (0.26%)

11:23
07/18/19
07/18
11:23
07/18/19
11:23
Periodicals
Breaking Periodicals news story on Booking Holdings »

Hedgeye adds Booking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$123.46

-0.2 (-0.16%)

11:20
07/18/19
07/18
11:20
07/18/19
11:20
Options
Put buyer in Investment Grade Corporate Bond ETF »

Put buyer in Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULC

Fulcrum Therapeutics

$0.00

(0.00%)

11:18
07/18/19
07/18
11:18
07/18/19
11:18
Syndicate
Breaking Syndicate news story on Fulcrum Therapeutics »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
07/18/19
07/18
11:17
07/18/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
07/18/19
07/18
11:16
07/18/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
07/18/19
07/18
11:15
07/18/19
11:15
General news
Treasury announced a $113 B 3-pronged package of shorter coupons »

Treasury announced a $113…

11:15
07/18/19
07/18
11:15
07/18/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
07/18/19
07/18
11:15
07/18/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

XOP

SPDR Oil Exploration and Production Fund

$24.46

-0.15 (-0.61%)

11:10
07/18/19
07/18
11:10
07/18/19
11:10
Options
Size put rolldown in Oil and Gas Exploration ETF »

Size put rolldown in Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
5-Yr Note Announcement CUSIP Number data reported »

5-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
5-Yr Note Announcement Offering Amount data reported »

5-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
7-Yr Note Announcement CUSIP Number data reported »

7-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr Note Announcement CUSIP Number data reported »

2-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
7-Yr Note Announcement Offering Amount data reported »

7-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr Note Announcement Offering Amount data reported »

2-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr FRN Note Announcement CUSIP Number data reported »

2-Yr FRN Note…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD is on…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr FRN Note Announcement Offering Amount data reported »

2-Yr FRN Note…

11:09
07/18/19
07/18
11:09
07/18/19
11:09
General news
3-Month Bill Announcement Offering Amount data reported »

3-Month Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.